| Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)? (NCT05357781) | Insel Gruppe AG, University Hospital Bern | 2022-07-01 |
| Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) (NCT04502030) | Octapharma | 2020-10-05 |
| Immunodeficiency in MS (NCT04447937) | Advanced Neurosciences Institute | 2020-06-29 |
| Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis (NCT04283747) | Mazandaran University of Medical Sciences | 2020-02-28 |
| Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients (NCT03401268) | University Health Network, Toronto | 2018-02-01 |
| Personalized Immunotherapeutic for Antibiotic-resistant Infection (NCT02508584) | Brigham and Women's Hospital | 2016-04-12 |
| Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome (NCT02231879) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-14 |
| Post-bypass Prophylactic IVIG in Infants and Neonates (NCT02043379) | University of Alabama at Birmingham | 2014-05-01 |
| Investigation of Immune Disorders and Deficiencies (NCT01981785) | O & O Alpan LLC | 2012-12-01 |
| Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) (NCT01581593) | Kedrion S.p.A. | 2012-11-12 |
| Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01002755) | M.D. Anderson Cancer Center | 2010-01-19 |
| Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. (NCT00278954) | Bio Products Laboratory | 2006-01-01 |
| Intravenous Immunoglobulin (IVIG) in Lung Transplantation (NCT00115778) | Columbia University | 2005-06-01 |
| Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia) (NCT00161993) | Baxalta now part of Shire | 2002-06-13 |
| Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients (NCT00138697) | Prothya Biosolutions | 2001-05-01 |
| Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients (NCT00137748) | The Cleveland Clinic | 2001-01-01 |